1. Koga K, Yamagishi S, Takeuchi M, Inagaki Y, Amano S, Okamoto T, Saga T, Makita Z, Yoshizuka M (2002) CS-866, a new angiotensin II type 1 receptor antagonist, ameliorates glomerular anionic site loss and prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats. Mol Med Camb MA NY 8(10):591–599
2. Schwocho LR, Masonson HN (2001) Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. J Clin Pharmacol 41(5):515–527
3. Celebier M, Altinoz S (2007) Determination of olmesartan medoxomil in tablets by UV-Vis spectrophotometry. Pharm Int J Pharm Sci 62(6):419–422
4. Gowrishankar D, Sharma T, Si S (2010) Difference spectrophotometric method for the determination of olmesartan medoxomil in tablets. J Pharm Res 3(7)
5. Patel J, Kevin G, Patel A, Raval M, Sheth N (2011) Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies. Pharm Methods 2(1):36